[go: up one dir, main page]

ES2027518A6 - Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica. - Google Patents

Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.

Info

Publication number
ES2027518A6
ES2027518A6 ES909003173A ES9003173A ES2027518A6 ES 2027518 A6 ES2027518 A6 ES 2027518A6 ES 909003173 A ES909003173 A ES 909003173A ES 9003173 A ES9003173 A ES 9003173A ES 2027518 A6 ES2027518 A6 ES 2027518A6
Authority
ES
Spain
Prior art keywords
associations
pharmacological activity
new non
protein associations
preparing new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES909003173A
Other languages
English (en)
Inventor
Gomez-Pamo Antonio Guerrero
Lacy Sureda Rafael De
Tuduri Jose Antonio Matji
Ranieri Juan Pablo Pivel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica Cantabria SA
Original Assignee
Laboratorios Andromaco SA
Corlay SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Andromaco SA, Corlay SL filed Critical Laboratorios Andromaco SA
Priority to ES909003173A priority Critical patent/ES2027518A6/es
Priority to DE69107815T priority patent/DE69107815T2/de
Priority to EP91112217A priority patent/EP0491114B1/en
Priority to JP3329038A priority patent/JPH05262661A/ja
Publication of ES2027518A6 publication Critical patent/ES2027518A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION CONSISTE EN UN PROCEDIMIENTO PARA LA PREPARACION DE ASOCIACIONES NO COVALENTES POLISACARIDO-PROTEINA CON ACTIVIDAD FARMACOLOGICA INMUNOMODULADORA Y ESTIMULADORA DE LA RECUPERACION HEMATOPOYETICA QUE SE CARACTERIZA PORQUE SE OBTIENEN DICHAS ASOCIACIONES A PARTIR DE LAS CORRESPONDIENTES COMBINACIONES SELECCIONADAS DE SEMILLAS O SUS HARINAS Y LEVADURAS MUERTAS O SUS EXTRACTOS SECOS TRAS UN PROCESO FERMENTATIVO EXTRACTIVO ESPONTANEO Y CONTROLADO EN UN MEDIO ESPECIFICO SEGUIDO DE UNA LISIS QUIMICO-ENZIMATICA CONTROLADA Y DE UN PROCESO DE CONCENTRACION Y ULTERIOR PURIFICACION POR ADSORCION O DIALISIS EXHAUSTIVA Y SECADO. DICHAS ASOCIACIONES PREPARADAS EN LAS FORMAS GALENICAS ADECUADAS SON DE USO EN CLINICA HUMANA Y ANIMAL. TIENE APLICACION EN LA INDUSTRIA FARMACEUTICA.
ES909003173A 1990-12-12 1990-12-18 Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica. Expired - Lifetime ES2027518A6 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES909003173A ES2027518A6 (es) 1990-12-18 1990-12-18 Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.
DE69107815T DE69107815T2 (de) 1990-12-18 1991-07-22 Verfahren zur Herstellung neuer nichtkovalenten Polysaccharid-Protein-Zusammensetzungen mit pharmakologischen Eigenschaften.
EP91112217A EP0491114B1 (en) 1990-12-18 1991-07-22 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity
JP3329038A JPH05262661A (ja) 1990-12-12 1991-12-12 薬理活性を有する、共有結合されていない多糖−タンパク質組合せ体の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES909003173A ES2027518A6 (es) 1990-12-18 1990-12-18 Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.

Publications (1)

Publication Number Publication Date
ES2027518A6 true ES2027518A6 (es) 1992-06-01

Family

ID=8270013

Family Applications (1)

Application Number Title Priority Date Filing Date
ES909003173A Expired - Lifetime ES2027518A6 (es) 1990-12-12 1990-12-18 Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.

Country Status (4)

Country Link
EP (1) EP0491114B1 (es)
JP (1) JPH05262661A (es)
DE (1) DE69107815T2 (es)
ES (1) ES2027518A6 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06166631A (ja) * 1991-02-22 1994-06-14 King Jozo Kk 脱変異原剤
FR2735497B1 (fr) * 1995-06-13 1997-07-25 Inst Francais Du Petrole Procede et milieu de production de gellane en presence de manganese
JP3217278B2 (ja) * 1996-10-21 2001-10-09 株式会社 エフェクト 落花生種皮処理物を用いた造血機能回復剤及び加工食品
BR0208901A (pt) * 2001-04-05 2004-06-29 Granada Bio Tech Sa De Cv Biopolìmeros de fosfoamida policarboxìlicos polissubstituìdos, métodos para sua produção e usos de composições derivadas destes
IL188647A0 (en) 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
NZ597326A (en) 2009-07-09 2013-05-31 Oshadi Drug Administration Ltd Matrix carrier compositions, methods and uses
IL294944A (en) 2020-01-28 2022-09-01 Genentech Inc Il15/il15r alpha heterodimeric fc-fusion proteins for the treatment of cancer
US12180307B2 (en) 2022-06-13 2024-12-31 B.A.I. Laboratories, Llc Interleukin-13 binding cyclic oligopeptides and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE770252L (en) * 1977-02-07 1978-08-07 Shafer La V Cobalt-containing animal feed supplement and microbial¹growth factor
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
ES8701229A1 (es) * 1985-06-03 1986-11-16 Corlay Sl Un procedimiento para la obtencion de un polisacarido nitro-genado aislado en forma de adsorbato
EP0349607A1 (en) * 1987-11-24 1990-01-10 BOGDANYNE FORGACS, Olga Preparation and use of plants of improved biological value

Also Published As

Publication number Publication date
JPH05262661A (ja) 1993-10-12
DE69107815D1 (de) 1995-04-06
DE69107815T2 (de) 1996-07-25
EP0491114A1 (en) 1992-06-24
EP0491114B1 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
ATE154822T1 (de) Präparate von fettlöslichen substanzen
CA2214503A1 (en) Method for treating tumors
NL178013C (nl) Werkwijze voor het bereiden van een celvrije herpesvirussuspensie of een gevriesdroogd produkt daarvan, alsmede een werkwijze voor het bereiden van een vaccin uit een aldus verkregen suspensie of produkt.
ES2027518A6 (es) Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.
EP0308197A3 (en) Method for stimulating the immune system
NO971683L (no) Lyofilisert farmasöytisk preparat som gjör vandige medikamentblandinger reversibelt termogelatinerende
HUP9900654A3 (en) Preparations stimulating nail growth, process for their preparation and use of them
FR2689508B1 (fr) Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.
ATE86489T1 (de) Hilfsmittelfreie riboflavingranulate.
EP0220453A3 (en) Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same
HUP9601305A3 (en) Fluorine-containing benzoyl-guanidine derivatives, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
CA2283676A1 (en) Stimulation, culture and preservation of pancreatic and other cells
JPS5679622A (en) Antitumor pharmaceutical
DE3680183D1 (de) Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut, nach diesem verfahren erhaltenes granulat und dessen verwendung zur herstellung von pharmazeutischen praeparaten.
RU96118931A (ru) Средство для воздействия на организм
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
HUP9602331A3 (en) Alkenyl-benzoyl-guanidine derivatives, pharmaceutical compns. contg. the said compds., process for preparing them and the use of the compds.
IE36320B1 (en) Enzyme treatment of legumes and derived products
TH9825A (th) สารแขวนลอยทางเภสัชกรรมในน้ำสำหรับสารแสดงฤทธิทางเภสัชกรรมที่ไม่ละลายน้ำ
IS3947A (is) Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja
RU94024323A (ru) Способ получения сухой биомассы лакто-, коли- или бифидобактерий
Pereverzev et al. The role of APUD-system cells and their mediators in the biological effects of adaptogenes

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. (TITULAR A